Sorafenib in combination with intensive chemotherapy for relapsed or refractory FLT3-ITD positive acute myeloid leukemia: A two centers experience

IF 2.1 4区医学 Q3 HEMATOLOGY Leukemia research Pub Date : 2024-01-01 DOI:10.1016/j.leukres.2023.107421

Irene Urbino, Carolina Secreto, Vincenzo Apolito, Matteo Olivi, Giulia Arrigo, Eleonora Boscaro, Federica Maria Catania, Stefano D’Ardia, Chiara Frairia, Valentina Giai, Roberto Freilone, Benedetto Bruno, Giuseppe Lanzarone, Luisa Giaccone, Alessandro Busca, Chiara Maria Dellacasa, Dario Ferrero, Ernesta Audisio, Marco Cerrano

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

索拉非尼联合强化化疗治疗复发或难治性FLT3-ITD阳性急性髓性白血病:两个中心的经验

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Leukemia research 医学-血液学

CiteScore

4.00

自引率

3.70%

发文量

259

审稿时长

1 months

期刊介绍： Leukemia Research an international journal which brings comprehensive and current information to all health care professionals involved in basic and applied clinical research in hematological malignancies. The editors encourage the submission of articles relevant to hematological malignancies. The Journal scope includes reporting studies of cellular and molecular biology, genetics, immunology, epidemiology, clinical evaluation, and therapy of these diseases.